更多...
收起
The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
[中文简述(自动翻译):]  由该基因编码的蛋白质催化5,10-亚甲基四氢叶酸向5-甲基,共底物高半胱氨酸remethylation到甲硫氨酸的转换。这种基因影响易感性的遗传变异为闭塞性血管疾病,神经管畸形,结肠癌和急性白血病,而且突变这个基因与甲基四氢叶酸还原酶缺乏有关。[由RefSeq的,2009年10月提供]
MTHFR基因(以及对应的蛋白质)的细胞分布位置:
MTHFR基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY | 0.362171535 | 11 | 44 | BeFree_CLINVAR_ORPHANET_UNIPROT |
| Hyperhomocysteinemia | 0.337316502 | 368 | 22 | BeFree_CTD_human_GAD_LHGDN |
| Cerebrovascular accident | 0.257121971 | 139 | 7 | BeFree_CTD_human_GAD_LHGDN |
| Cardiovascular Diseases | 0.244595919 | 116 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Down Syndrome | 0.239186945 | 59 | 8 | BeFree_CTD_human_GAD_LHGDN |
| Coronary heart disease | 0.238855914 | 126 | 8 | BeFree_CTD_human_GAD_LHGDN |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.232099662 | 79 | 7 | BeFree_CTD_human_GAD_LHGDN |
| Stomach Neoplasms | 0.225984318 | 38 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Neural Tube Defects | 0.221794802 | 41 | 0 | CTD_human_GAD_LHGDN |
| Schizophrenia | 0.218796007 | 61 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Thrombophilia | 0.216296444 | 126 | 1 | BeFree_CTD_human_GAD_LHGDN |
| Venous Thrombosis | 0.208173051 | 49 | 0 | CTD_human_GAD_LHGDN |
| Rheumatoid Arthritis | 0.20430773 | 49 | 8 | BeFree_CTD_human_GAD_LHGDN |
| Colorectal Neoplasms | 0.203028635 | 40 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Brain Ischemia | 0.200836406 | 35 | 0 | CTD_human_GAD_LHGDN |
| Neural tube defect, folate-sensitive | 0.2 | 0 | 0 | CTD_human_MGD |
| Alzheimer's Disease | 0.189620074 | 35 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Cleft Lip | 0.181419398 | 26 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Congenital Heart Defects | 0.167849848 | 29 | 1 | BeFree_CTD_human_GAD_LHGDN |
| Colonic Neoplasms | 0.162754584 | 18 | 1 | BeFree_CTD_human_GAD_LHGDN |
| Mammary Neoplasms | 0.160507935 | 16 | 0 | CTD_human_GAD_LHGDN |
| Vascular Diseases | 0.155222768 | 67 | 2 | BeFree_CTD_human_GAD |
| Male infertility | 0.148446653 | 27 | 3 | BeFree_CTD_human_GAD_LHGDN |
| Homocysteinemia | 0.146231817 | 244 | 22 | BeFree_MGD |
| Lymphoma | 0.144189459 | 14 | 1 | BeFree_CTD_human_GAD_LHGDN |
| Graft-vs-Host Disease | 0.142746374 | 8 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Bipolar Disorder | 0.140812605 | 15 | 3 | BeFree_CTD_human_GAD_LHGDN |
| Pulmonary Embolism | 0.140564907 | 13 | 0 | BeFree_CTD_human_GAD |
| Hearing Loss, Sudden | 0.136926542 | 6 | 0 | CTD_human_GAD_LHGDN |
| Lymphoma, Non-Hodgkin | 0.136916611 | 13 | 1 | BeFree_CTD_human_GAD |
| Uterine Cervical Neoplasm | 0.136569224 | 7 | 0 | CTD_human_GAD |
| Cervical Intraepithelial Neoplasia | 0.135992664 | 14 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Prostatic Neoplasms | 0.135631465 | 6 | 0 | CTD_human_GAD_LHGDN |
| Coronary Artery Disease | 0.135211947 | 114 | 5 | BeFree_GAD_LHGDN |
| Chronic Lymphocytic Leukemia | 0.135102394 | 7 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Kidney Diseases | 0.135092462 | 17 | 3 | BeFree_CTD_human_GAD |
| Lung Neoplasms | 0.132907115 | 5 | 0 | CTD_human_GAD_LHGDN |
| Bladder Neoplasm | 0.132821238 | 6 | 5 | BeFree_CTD_human_GAD_LHGDN |
| Hematological Disease | 0.132192478 | 5 | 0 | CTD_human_GAD_LHGDN |
| Diabetic Angiopathies | 0.132106602 | 7 | 0 | BeFree_CTD_human_GAD |
| Blood Coagulation Disorders, Inherited | 0.13183516 | 6 | 0 | CTD_human_GAD |
| Drug-Induced Liver Injury | 0.13183516 | 7 | 0 | CTD_human_GAD |
| Autistic Disorder | 0.130825337 | 6 | 1 | BeFree_CTD_human_GAD |
| Liver diseases | 0.12973957 | 5 | 0 | BeFree_CTD_human_GAD |
| Anencephaly | 0.12827274 | 4 | 0 | BeFree_GAD_LHGDN_ORPHANET |
| Neutropenia | 0.127372538 | 5 | 0 | BeFree_CTD_human_GAD |
| Female infertility | 0.127101096 | 4 | 0 | CTD_human_GAD |
| Thrombocytopenia | 0.127101096 | 3 | 0 | CTD_human_GAD |
| Systemic arterial pressure | 0.127101096 | 3 | 1 | GAD_GWASCAT |
| Depressive disorder | 0.125971721 | 23 | 2 | BeFree_CTD_human |
| Anemia | 0.125819831 | 6 | 1 | BeFree_CTD_human_GAD |
| Lymphoma, Follicular | 0.125819831 | 5 | 0 | BeFree_CTD_human_GAD |
| Meningomyelocele | 0.125819831 | 6 | 1 | BeFree_CTD_human_GAD |
| Sinus Thrombosis, Intracranial | 0.12554839 | 6 | 0 | BeFree_CTD_human_GAD |
| Malnutrition | 0.12554839 | 5 | 1 | BeFree_CTD_human_GAD |
| nervous system disorder | 0.125005506 | 4 | 0 | BeFree_CTD_human_GAD |
| Gastrointestinal Diseases | 0.124734064 | 3 | 0 | CTD_human_GAD |
| Dermatologic disorders | 0.124734064 | 3 | 0 | CTD_human_GAD |
| Inflammatory disease of mucous membrane | 0.124734064 | 2 | 0 | CTD_human_GAD |
| Coronary Restenosis | 0.124734064 | 2 | 0 | CTD_human_GAD |
| Blood pressure finding | 0.124734064 | 2 | 1 | GAD_GWASCAT |
| Leukopenia | 0.123724241 | 6 | 0 | BeFree_CTD_human_GAD |
| Neoplasm Metastasis | 0.123452799 | 6 | 0 | BeFree_CTD_human_GAD |
| Congenital clubfoot | 0.122638474 | 1 | 0 | BeFree_CTD_human_GAD |
| Microvascular Angina | 0.122638474 | 1 | 0 | BeFree_CTD_human_GAD |
| Methylenetetrahydrofolate reductase deficiency | 0.122638474 | 2 | 0 | BeFree_CTD_human_GAD |
| Atrial Fibrillation | 0.122367032 | 1 | 1 | GAD_GWASCAT |
| Endometrial Neoplasms | 0.122367032 | 1 | 0 | CTD_human_GAD |
| Arsenic Poisoning | 0.122367032 | 2 | 0 | CTD_human_GAD |
| Peripheral Neuropathy | 0.120542884 | 3 | 1 | BeFree_CTD_human |
| OROFACIAL CLEFT 1 | 0.120542884 | 2 | 1 | BeFree_CTD_human |
| Spinal Cord Diseases | 0.120271442 | 1 | 0 | BeFree_CTD_human |
| Thyrotoxicosis | 0.120271442 | 1 | 0 | BeFree_CTD_human |
| Alopecia | 0.12 | 1 | 0 | CTD_human |
| Drug Eruptions | 0.12 | 1 | 0 | CTD_human |
| Hypersensitivity | 0.12 | 1 | 0 | CTD_human |
| Necrosis | 0.12 | 1 | 0 | CTD_human |
| Adverse reaction to drug | 0.12 | 11 | 0 | CTD_human |
| Gastrointestinal Stromal Tumors | 0.12 | 0 | 2 | CLINVAR |
| Leukoencephalopathies | 0.12 | 1 | 0 | CTD_human |
| Maxillofacial Abnormalities | 0.12 | 1 | 0 | CTD_human |
| Microsatellite Instability | 0.12 | 1 | 0 | CTD_human |
| Mthfr Deficiency, Thermolabile Type | 0.12 | 0 | 2 | CLINVAR |
| Acute kidney injury | 0.12 | 1 | 0 | CTD_human |
| Hypertensive disease | 0.114562501 | 76 | 7 | BeFree_GAD_LHGDN |
| Colorectal Cancer | 0.106872745 | 137 | 16 | BeFree_GAD |
| Malignant neoplasm of breast | 0.100901024 | 94 | 16 | BeFree_GAD |
| Liver neoplasms | 0.096926542 | 7 | 0 | GAD_LHGDN_RGD |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.093853467 | 70 | 8 | BeFree_GAD_LHGDN |
| Thrombosis | 0.093621751 | 51 | 1 | GAD_LHGDN |
| Hyperthyroidism | 0.082367032 | 2 | 0 | GAD_RGD |
| Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
| Hypothyroidism | 0.08 | 1 | 0 | RGD |
| Pre-Eclampsia | 0.074449946 | 29 | 0 | GAD_LHGDN |
| Myocardial Infarction | 0.069205336 | 45 | 9 | BeFree_GAD_LHGDN |
| Folic Acid Deficiency | 0.063866256 | 46 | 1 | BeFree_GAD |
| Kidney Failure, Chronic | 0.063333304 | 30 | 2 | BeFree_GAD_LHGDN |
| Atherosclerosis | 0.059303945 | 40 | 0 | BeFree_GAD_LHGDN |
| Malignant neoplasm of lung | 0.05676516 | 36 | 13 | BeFree_GAD |
| Migraine Disorders | 0.054288508 | 40 | 7 | BeFree_GAD_LHGDN |
| Adenocarcinoma | 0.053689542 | 21 | 0 | BeFree_GAD_LHGDN |
| Squamous cell carcinoma | 0.050398564 | 19 | 0 | BeFree_GAD_LHGDN |
| Thromboembolism | 0.048187303 | 51 | 2 | BeFree_GAD |
| Cleft Palate | 0.048154965 | 23 | 0 | BeFree_GAD |
| Abortion, Habitual | 0.047697958 | 20 | 0 | GAD_LHGDN |
| leukemia | 0.047207275 | 24 | 2 | BeFree_GAD_LHGDN |
| Coronary Arteriosclerosis | 0.046471437 | 91 | 5 | BeFree_GAD |
| Adenoma | 0.045369314 | 19 | 0 | BeFree_GAD_LHGDN |
| Spina Bifida | 0.044558869 | 32 | 2 | BeFree_GAD_LHGDN |
| Diabetic Nephropathy | 0.041711086 | 26 | 2 | BeFree_GAD_LHGDN |
| Malignant neoplasm of esophagus | 0.041672698 | 26 | 2 | BeFree_GAD |
| Spontaneous abortion | 0.037649389 | 14 | 0 | GAD_LHGDN |
| Malignant neoplasm of stomach | 0.036428088 | 53 | 3 | BeFree_GAD |
| Pregnancy loss | 0.03550548 | 15 | 0 | GAD |
| Venous Thromboembolism | 0.033495766 | 14 | 0 | GAD_LHGDN |
| Retinal Vein Occlusion | 0.033214393 | 20 | 1 | BeFree_GAD |
| Esophageal Neoplasms | 0.032647765 | 24 | 2 | BeFree_GAD_LHGDN |
| Malignant neoplasm of urinary bladder | 0.032476012 | 20 | 3 | BeFree_GAD |
| Abruptio Placentae | 0.031843371 | 10 | 0 | GAD_LHGDN |
| Pregnancy Complications | 0.031747563 | 19 | 2 | BeFree_GAD_LHGDN |
| Leukemia, Lymphocytic, Acute, L1 | 0.030532311 | 38 | 2 | BeFree_GAD |
| Malignant neoplasm of prostate | 0.03010898 | 19 | 3 | BeFree_GAD |
| Liver carcinoma | 0.029823725 | 12 | 1 | BeFree_GAD_LHGDN |
| Parkinson Disease | 0.029661904 | 13 | 1 | BeFree_GAD_LHGDN |
| Obesity | 0.029294654 | 18 | 2 | BeFree_GAD |
| Ischemic stroke | 0.02920744 | 67 | 6 | BeFree_GAD |
| Postoperative Complications | 0.028404384 | 12 | 0 | GAD |
| Pregnancy Complications, Hematologic | 0.028404384 | 12 | 0 | GAD |
| Colorectal Carcinoma | 0.026329862 | 97 | 14 | BeFree |
| Activated Protein C Resistance | 0.025841855 | 18 | 1 | BeFree_GAD |
| Glaucoma, Open-Angle | 0.025828042 | 11 | 1 | BeFree_GAD_LHGDN |
| Liver Cirrhosis | 0.025742166 | 11 | 0 | BeFree_GAD_LHGDN |
| Arteriosclerosis | 0.025722303 | 31 | 0 | BeFree_GAD |
| Anemia, Sickle Cell | 0.025103474 | 19 | 1 | BeFree_GAD |
| Polycystic Ovary Syndrome | 0.024732343 | 12 | 0 | BeFree_GAD_LHGDN |
| Cerebrovascular Disorders | 0.02367032 | 10 | 0 | GAD |
| Myocardial Ischemia | 0.023203381 | 15 | 0 | BeFree_GAD |
| Peripheral Vascular Diseases | 0.023103692 | 9 | 0 | BeFree_GAD_LHGDN |
| Epilepsy | 0.022636753 | 14 | 2 | BeFree_GAD_LHGDN |
| Osteoporosis | 0.022365311 | 14 | 2 | BeFree_GAD_LHGDN |
| Premature Birth | 0.021660606 | 9 | 0 | GAD_LHGDN |
| DNA Damage | 0.021303288 | 9 | 0 | GAD |
| Myeloid Leukemia, Chronic | 0.021084047 | 16 | 1 | BeFree_GAD_LHGDN |
| Multiple Myeloma | 0.020922225 | 10 | 1 | BeFree_GAD_LHGDN |
| Ulcerative Colitis | 0.020650783 | 10 | 1 | BeFree_GAD_LHGDN |
| Breast Carcinoma | 0.020629582 | 76 | 16 | BeFree |
| Aortic Aneurysm, Abdominal | 0.020379342 | 9 | 0 | BeFree_GAD_LHGDN |
| Alcoholic Intoxication, Chronic | 0.020293465 | 9 | 0 | BeFree_GAD |
| Rectal Neoplasms | 0.020193776 | 9 | 0 | BeFree_GAD_LHGDN |
| Mental Depression | 0.019902471 | 24 | 0 | BeFree_GAD |
| Diabetes Mellitus | 0.01953134 | 22 | 2 | BeFree_GAD_LHGDN |
| Vitamin B 12 Deficiency | 0.018740759 | 14 | 0 | BeFree_GAD |
| Factor V Leiden mutation | 0.018729489 | 69 | 8 | BeFree |
| Deep Vein Thrombosis | 0.018621207 | 28 | 1 | BeFree_GAD |
| Congenital Abnormality | 0.017078432 | 19 | 2 | BeFree_GAD_LHGDN |
| Bone necrosis | 0.016926542 | 7 | 0 | GAD_LHGDN |
| Pancreatic Neoplasm | 0.016926542 | 6 | 0 | GAD_LHGDN |
| Leukemia, Myelocytic, Acute | 0.016731045 | 12 | 2 | BeFree_GAD_LHGDN |
| Inflammatory Bowel Diseases | 0.016645169 | 13 | 1 | BeFree_GAD |
| Fetal Growth Retardation | 0.016569224 | 7 | 0 | GAD |
| Behcet Syndrome | 0.016102285 | 10 | 1 | BeFree_GAD |
| Acute lymphocytic leukemia | 0.01601507 | 59 | 7 | BeFree |
| Metabolic Syndrome X | 0.015635346 | 16 | 4 | BeFree_GAD |
| Ischemic Cerebrovascular Accident | 0.015472187 | 57 | 5 | BeFree |
| Diabetes Mellitus, Insulin-Dependent | 0.015287959 | 8 | 1 | BeFree_GAD |
| Carotid Artery Diseases | 0.014916828 | 5 | 0 | GAD_LHGDN |
| Diabetic Retinopathy | 0.014635455 | 12 | 1 | BeFree_GAD_LHGDN |
| beta Thalassemia | 0.014473634 | 7 | 0 | BeFree_GAD |
| Neoplasm Recurrence, Local | 0.014202192 | 6 | 0 | GAD |
| Osteoporosis, Postmenopausal | 0.014202192 | 6 | 0 | GAD |
| Hyperhomocystinemia | 0.014202192 | 6 | 0 | GAD |
| Migraine with Aura | 0.013897074 | 16 | 0 | BeFree_GAD_LHGDN |
| Carcinogenesis | 0.013843535 | 51 | 3 | BeFree |
| Asthma | 0.013278246 | 7 | 0 | BeFree_GAD_LHGDN |
| Diffuse Large B-Cell Lymphoma | 0.013192369 | 8 | 6 | BeFree_GAD |
| Stomach Carcinoma | 0.01302921 | 48 | 3 | BeFree |
| Antiphospholipid Syndrome | 0.013006804 | 8 | 0 | BeFree_GAD_LHGDN |
| Exfoliation Syndrome | 0.013006804 | 6 | 0 | BeFree_GAD_LHGDN |
| Cerebral Infarction | 0.01272543 | 14 | 1 | BeFree_GAD |
| Malignant neoplasm of ovary | 0.01272543 | 13 | 7 | BeFree_GAD |
| Fatty Liver | 0.012106602 | 6 | 1 | BeFree_GAD |
| Hyperlipidemia | 0.012106602 | 6 | 0 | BeFree_GAD |
| Head and Neck Neoplasms | 0.01183516 | 5 | 0 | GAD |
| Inflammation | 0.01183516 | 5 | 0 | GAD |
| Mouth Neoplasms | 0.01183516 | 5 | 0 | GAD |
| Complications of Diabetes Mellitus | 0.01183516 | 5 | 0 | GAD |
| Methotrexate poisoning | 0.01183516 | 5 | 0 | GAD |
| Hyperuricemia | 0.011811416 | 6 | 0 | BeFree_GAD_LHGDN |
| Transient Ischemic Attack | 0.011368221 | 10 | 1 | BeFree_GAD |
| Lupus Erythematosus, Systemic | 0.011368221 | 9 | 1 | BeFree_GAD |
| Protein C Deficiency | 0.011096779 | 10 | 0 | BeFree_GAD |
| Hepatitis C, Chronic | 0.010911214 | 5 | 0 | BeFree_GAD_LHGDN |
| Multiple Sclerosis | 0.010825337 | 7 | 2 | BeFree_GAD |
| Protein S Deficiency | 0.010825337 | 8 | 0 | BeFree_GAD |
| Meningioma | 0.010639772 | 5 | 0 | BeFree_GAD_LHGDN |
| Hematologic Neoplasms | 0.010639772 | 7 | 0 | BeFree_GAD_LHGDN |
| Arterial Occlusive Diseases | 0.010553895 | 7 | 0 | BeFree_GAD |
| Brain Neoplasms | 0.01036833 | 5 | 0 | BeFree_GAD_LHGDN |
| Blood Coagulation Disorders | 0.010282454 | 7 | 2 | BeFree_GAD |
| Crohn Disease | 0.010282454 | 7 | 0 | BeFree_GAD |
| HELLP Syndrome | 0.010282454 | 5 | 0 | BeFree_GAD |
| Cervix carcinoma | 0.010162901 | 21 | 7 | BeFree_GAD |
| Lymphoproliferative Disorders | 0.010011012 | 4 | 0 | BeFree_GAD |
| Optic Neuropathy, Ischemic | 0.009825446 | 3 | 0 | GAD_LHGDN |
| Chromosome Aberrations | 0.009468128 | 4 | 0 | GAD |
| Pregnancy Complications, Cardiovascular | 0.009468128 | 4 | 0 | GAD |
| Prenatal Exposure Delayed Effects | 0.009468128 | 4 | 0 | GAD |
| Intracranial Thrombosis | 0.009468128 | 4 | 0 | GAD |
| Chronic ulcerative colitis | 0.009468128 | 4 | 0 | GAD |
| Azoospermia | 0.009001189 | 9 | 1 | BeFree_GAD |
| Dementia | 0.009001189 | 9 | 0 | BeFree_GAD |
| Glioblastoma | 0.008630058 | 3 | 2 | BeFree_GAD_LHGDN |
| Sensorineural Hearing Loss (disorder) | 0.008458305 | 7 | 0 | BeFree_GAD |
| Psoriasis | 0.008458305 | 5 | 0 | BeFree_GAD |
| Left Ventricular Hypertrophy | 0.008358616 | 3 | 0 | BeFree_GAD_LHGDN |
| Carotid Stenosis | 0.00827274 | 6 | 0 | BeFree_GAD_LHGDN |
| Huntington Disease | 0.00827274 | 3 | 2 | BeFree_GAD_LHGDN |
| Glaucoma | 0.008186863 | 6 | 0 | BeFree_GAD |
| Oligospermia | 0.008186863 | 6 | 1 | BeFree_GAD |
| B-Cell Lymphomas | 0.008087174 | 4 | 0 | BeFree_GAD_LHGDN |
| Angle Closure Glaucoma | 0.008001298 | 2 | 1 | BeFree_GAD_LHGDN |
| Eclampsia | 0.007991366 | 13 | 0 | BeFree_GAD |
| Ischemia | 0.007915422 | 5 | 0 | BeFree_GAD |
| Osteosarcoma | 0.007729856 | 2 | 0 | BeFree_GAD_LHGDN |
| Heart Diseases | 0.00764398 | 5 | 2 | BeFree_GAD |
| Hemophilia A | 0.00764398 | 4 | 1 | BeFree_GAD |
| Hypercholesterolemia | 0.00764398 | 5 | 1 | BeFree_GAD |
| Brain Infarction | 0.00764398 | 4 | 0 | BeFree_GAD |
| Malignant tumor of colon | 0.007524428 | 20 | 1 | BeFree_GAD |
| Infection | 0.007458414 | 3 | 0 | GAD_LHGDN |
| Cerebral Palsy | 0.007372538 | 4 | 0 | BeFree_GAD |
| Hemolytic-Uremic Syndrome | 0.007372538 | 3 | 0 | BeFree_GAD |
| Liver Cirrhosis, Alcoholic | 0.007372538 | 3 | 0 | BeFree_GAD |
| Metabolic Diseases | 0.007372538 | 4 | 0 | BeFree_GAD |
| Retinal Artery Occlusion | 0.007372538 | 3 | 0 | BeFree_GAD |
| T-Cell Lymphoma | 0.007372538 | 3 | 0 | BeFree_GAD |
| Central Nervous System Neoplasms | 0.007372538 | 3 | 1 | BeFree_GAD |
| Dementia, Vascular | 0.007177041 | 10 | 0 | BeFree_GAD |
| Drug toxicity | 0.007101096 | 3 | 0 | GAD |
| Fetal Diseases | 0.007101096 | 3 | 0 | GAD |
| Gastrointestinal Neoplasms | 0.007101096 | 3 | 0 | GAD |
| Insulin Resistance | 0.007101096 | 3 | 0 | GAD |
| Premature Obstetric Labor | 0.007101096 | 3 | 0 | GAD |
| Skin Neoplasms | 0.007101096 | 3 | 0 | GAD |
| Age related macular degeneration | 0.007101096 | 3 | 0 | GAD |
| Papillomavirus Infections | 0.007101096 | 3 | 0 | GAD |
| Carcinoma of lung | 0.007057489 | 26 | 13 | BeFree |
| Homocystinuria | 0.005819831 | 6 | 0 | BeFree_GAD |
| Mental Retardation | 0.005819831 | 5 | 1 | BeFree_GAD |
| ovarian neoplasm | 0.005720142 | 3 | 0 | BeFree_LHGDN |
| Malignant tumor of cervix | 0.005700279 | 21 | 7 | BeFree |
| Hyperglycemia | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
| Budd-Chiari Syndrome | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
| Arterial thrombosis | 0.005624334 | 13 | 0 | BeFree_GAD |
| Celiac Disease | 0.00554839 | 5 | 1 | BeFree_GAD |
| Glioma | 0.00554839 | 4 | 0 | BeFree_GAD |
| Hypercholesterolemia, Familial | 0.00554839 | 3 | 0 | BeFree_GAD |
| Turner Syndrome | 0.00554839 | 4 | 1 | BeFree_GAD |
| Adenomatous Polyps | 0.00554839 | 4 | 0 | BeFree_GAD |
| Common Migraine | 0.00554839 | 5 | 0 | BeFree_GAD |
| Kidney Failure | 0.005428837 | 20 | 1 | BeFree |
| Chondrosarcoma | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
| Acute leukemia | 0.005352893 | 11 | 1 | BeFree_GAD |
| Aneurysm, Dissecting | 0.005276948 | 4 | 0 | BeFree_GAD |
| Foramen Ovale, Patent | 0.005276948 | 3 | 0 | BeFree_GAD |
| Lymphoid leukemia | 0.005276948 | 3 | 0 | BeFree_GAD |
| Trisomy | 0.005276948 | 3 | 0 | BeFree_GAD |
| Avitaminosis | 0.005276948 | 4 | 0 | BeFree_GAD |
| Juvenile arthritis | 0.005276948 | 2 | 0 | BeFree_GAD |
| Colon Carcinoma | 0.005157396 | 19 | 1 | BeFree |
| Dislocations | 0.005091382 | 1 | 0 | GAD_LHGDN |
| Atrophic | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Leukoaraiosis | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Cerebral Hemorrhage | 0.005091382 | 1 | 0 | GAD_LHGDN |
| Non-Small Cell Lung Carcinoma | 0.005081451 | 11 | 1 | BeFree_GAD |
| Intracranial Aneurysm | 0.005005506 | 2 | 0 | BeFree_GAD |
| Gaucher Disease | 0.005005506 | 3 | 0 | BeFree_GAD |
| Neoplasms, Second Primary | 0.005005506 | 2 | 0 | BeFree_GAD |
| Cataract | 0.005005506 | 2 | 0 | BeFree_GAD |
| Coronary Stenosis | 0.005005506 | 3 | 0 | BeFree_GAD |
| Carotid Atherosclerosis | 0.004810009 | 9 | 1 | BeFree_GAD |
| Major Depressive Disorder | 0.004810009 | 10 | 2 | BeFree_GAD |
| Burkitt Lymphoma | 0.004734064 | 2 | 0 | GAD |
| Neoplastic Cell Transformation | 0.004734064 | 2 | 0 | GAD |
| Choline Deficiency | 0.004734064 | 2 | 0 | GAD |
| Edema | 0.004734064 | 2 | 0 | GAD |
| Fetal Membranes, Premature Rupture | 0.004734064 | 2 | 0 | GAD |
| Gastrointestinal Hemorrhage | 0.004734064 | 2 | 0 | GAD |
| Hyperplasia | 0.004734064 | 2 | 0 | GAD |
| Immediate hypersensitivity | 0.004734064 | 2 | 0 | GAD |
| Infertility | 0.004734064 | 2 | 0 | GAD |
| Laryngeal neoplasm | 0.004734064 | 2 | 0 | GAD |
| Chronic Obstructive Airway Disease | 0.004734064 | 2 | 0 | GAD |
| Pharyngeal Neoplasms | 0.004734064 | 2 | 0 | GAD |
| Placenta Disorders | 0.004734064 | 2 | 0 | GAD |
| Precancerous Conditions | 0.004734064 | 2 | 0 | GAD |
| Retinal vascular occlusion | 0.004734064 | 2 | 0 | GAD |
| Thromboangiitis Obliterans | 0.004734064 | 2 | 0 | GAD |
| Vitamin B Deficiency | 0.004734064 | 2 | 0 | GAD |
| Helicobacter Infections | 0.004734064 | 2 | 0 | GAD |
| Intracranial Hemorrhages | 0.004734064 | 2 | 0 | GAD |
| Vertebral Artery Dissection | 0.004734064 | 2 | 0 | GAD |
| Choroidal Neovascularization | 0.004734064 | 2 | 0 | GAD |
| Chronic progressive chorea | 0.004734064 | 2 | 0 | GAD |
| Carotid Artery, Internal, Dissection | 0.004734064 | 2 | 0 | GAD |
| Intracranial Arterial Diseases | 0.004734064 | 2 | 0 | GAD |
| Pregnancy associated hypertension | 0.004734064 | 2 | 0 | GAD |
| Adenoma of large intestine | 0.00434307 | 16 | 1 | BeFree |
| Congenital heart disease | 0.004071628 | 15 | 1 | BeFree |
| Squamous cell carcinoma of esophagus | 0.004071628 | 15 | 2 | BeFree |
| Prostate carcinoma | 0.004071628 | 15 | 3 | BeFree |
| Carcinoma of bladder | 0.004071628 | 15 | 3 | BeFree |
| Malignant neoplasm of pancreas | 0.003995683 | 6 | 0 | BeFree_GAD |
| Esophageal carcinoma | 0.003800186 | 14 | 2 | BeFree |
| Deep vein thrombosis of lower limb | 0.003800186 | 14 | 0 | BeFree |
| Aortic Aneurysm | 0.003724241 | 6 | 2 | BeFree_GAD |
| Cancer of Head and Neck | 0.003724241 | 6 | 1 | BeFree_GAD |
| Renal Insufficiency | 0.003724241 | 6 | 0 | BeFree_GAD |
| Hepatitis C | 0.003538676 | 3 | 0 | BeFree_LHGDN |
| Myeloid Leukemia | 0.003538676 | 3 | 0 | BeFree_LHGDN |
| Ovarian Carcinoma | 0.003528744 | 13 | 7 | BeFree |
| Erectile dysfunction | 0.003452799 | 4 | 1 | BeFree_GAD |
| Restenosis | 0.003452799 | 5 | 0 | BeFree_GAD |
| Overweight | 0.003452799 | 4 | 2 | BeFree_GAD |
| Infiltrating Cervical Carcinoma | 0.003452799 | 4 | 0 | BeFree_GAD |
| polyps | 0.003267234 | 3 | 1 | BeFree_LHGDN |
| 5,10-Methylenetetrahydrofolate reductase deficiency | 0.003257302 | 12 | 1 | BeFree |
| prothrombin gene mutation | 0.003257302 | 12 | 1 | BeFree |
| Atrial Septal Defects | 0.003181358 | 3 | 0 | BeFree_GAD |
| Hepatitis B | 0.003181358 | 3 | 0 | BeFree_GAD |
| Low Tension Glaucoma | 0.003181358 | 4 | 0 | BeFree_GAD |
| Malignant neoplasm of liver | 0.003181358 | 4 | 3 | BeFree_GAD |
| Takayasu Arteritis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Pancreatitis, Chronic | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Lateral Sinus Thrombosis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Sarcoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Rectal Carcinoma | 0.002985861 | 11 | 1 | BeFree |
| Diabetes | 0.002985861 | 11 | 2 | BeFree |
| Essential Hypertension | 0.002985861 | 11 | 1 | BeFree |
| Impaired cognition | 0.002985861 | 11 | 3 | BeFree |
| early pregnancy | 0.002985861 | 11 | 1 | BeFree |
| Prothrombin G20210A mutation | 0.002985861 | 11 | 1 | BeFree |
| alpha-Thalassemia | 0.002909916 | 3 | 0 | BeFree_GAD |
| Cooley's anemia | 0.002909916 | 2 | 0 | BeFree_GAD |
| Bronchopulmonary Dysplasia | 0.002909916 | 3 | 0 | BeFree_GAD |
| Patent ductus arteriosus | 0.002909916 | 2 | 1 | BeFree_GAD |
| Hodgkin Disease | 0.002909916 | 3 | 0 | BeFree_GAD |
| Nephroblastoma | 0.002909916 | 2 | 4 | BeFree_GAD |
| Retinoblastoma | 0.002909916 | 2 | 5 | BeFree_GAD |
| Seizures | 0.002909916 | 3 | 0 | BeFree_GAD |
| Stomatitis | 0.002909916 | 3 | 0 | BeFree_GAD |
| Spina Bifida Occulta | 0.002909916 | 2 | 0 | BeFree_GAD |
| Bacterial Vaginosis | 0.002909916 | 2 | 0 | BeFree_GAD |
| Antithrombin III Deficiency | 0.002909916 | 3 | 0 | BeFree_GAD |
| Conventional (Clear Cell) Renal Cell Carcinoma | 0.002909916 | 2 | 1 | BeFree_GAD |
| Cardiac defects | 0.002909916 | 3 | 0 | BeFree_GAD |
| Congenital omphalocele | 0.002909916 | 2 | 2 | BeFree_GAD |
| Acute Coronary Syndrome | 0.002909916 | 3 | 0 | BeFree_GAD |
| Arthritis | 0.00272435 | 1 | 0 | LHGDN |
| Encephalomalacia | 0.00272435 | 1 | 0 | LHGDN |
| Infarction | 0.00272435 | 1 | 0 | LHGDN |
| Intellectual Disability | 0.00272435 | 1 | 0 | LHGDN |
| Unipolar Depression | 0.002714419 | 10 | 2 | BeFree |
| Acute myocardial infarction | 0.002714419 | 10 | 3 | BeFree |
| Adult Acute Lymphocytic Leukemia | 0.002714419 | 10 | 1 | BeFree |
| Cleft Lip with or without Cleft Palate | 0.002714419 | 10 | 3 | BeFree |
| Endothelial dysfunction | 0.002714419 | 10 | 3 | BeFree |
| Amyotrophic Lateral Sclerosis | 0.002638474 | 2 | 0 | BeFree_GAD |
| Aortic Valve Stenosis | 0.002638474 | 2 | 0 | BeFree_GAD |
| Arthritis, Psoriatic | 0.002638474 | 1 | 0 | BeFree_GAD |
| Bone Marrow Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
| Carcinoma, Transitional Cell | 0.002638474 | 2 | 0 | BeFree_GAD |
| Diabetic Neuropathies | 0.002638474 | 2 | 0 | BeFree_GAD |
| Diarrhea | 0.002638474 | 2 | 0 | BeFree_GAD |
| Gastritis, Atrophic | 0.002638474 | 2 | 0 | BeFree_GAD |
| Focal glomerulosclerosis | 0.002638474 | 1 | 0 | BeFree_GAD |
| Graves Disease | 0.002638474 | 1 | 0 | BeFree_GAD |
| Hepatitis, Chronic | 0.002638474 | 2 | 0 | BeFree_GAD |
| Pulmonary Hypertension | 0.002638474 | 2 | 0 | BeFree_GAD |
| Intermittent Claudication | 0.002638474 | 1 | 0 | BeFree_GAD |
| Legg-Calve-Perthes Disease | 0.002638474 | 2 | 0 | BeFree_GAD |
| Marfan Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
| Nausea | 0.002638474 | 2 | 0 | BeFree_GAD |
| Pregnancy in Diabetics | 0.002638474 | 1 | 0 | BeFree_GAD |
| Henoch-Schoenlein Purpura | 0.002638474 | 2 | 0 | BeFree_GAD |
| Riboflavin Deficiency | 0.002638474 | 2 | 0 | BeFree_GAD |
| Systemic Scleroderma | 0.002638474 | 1 | 0 | BeFree_GAD |
| Varicosity | 0.002638474 | 2 | 0 | BeFree_GAD |
| von Willebrand Disease | 0.002638474 | 1 | 0 | BeFree_GAD |
| Cerebral Thrombosis | 0.002638474 | 1 | 0 | BeFree_GAD |
| Depressive Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
| Essential Tremor | 0.002638474 | 1 | 1 | BeFree_GAD |
| Sleep Apnea, Obstructive | 0.002638474 | 1 | 0 | BeFree_GAD |
| Pulmonary Thromboembolisms | 0.002638474 | 2 | 0 | BeFree_GAD |
| Alcohol Withdrawal Seizures | 0.002638474 | 1 | 0 | BeFree_GAD |
| Skin carcinoma | 0.002638474 | 2 | 0 | BeFree_GAD |
| Optic Atrophy, Hereditary, Leber | 0.002638474 | 1 | 0 | BeFree_GAD |
| Thrombosis of retinal vein | 0.002638474 | 1 | 0 | BeFree_GAD |
| Fetus affected by placental transfer of anticonvulsant | 0.002638474 | 2 | 0 | BeFree_GAD |
| Thrombosis of cerebral veins | 0.002442977 | 9 | 1 | BeFree |
| Glaucoma, Primary Open Angle | 0.002442977 | 9 | 1 | BeFree |
| Albuminuria | 0.002367032 | 1 | 0 | GAD |
| Aneuploidy | 0.002367032 | 1 | 0 | GAD |
| Anoxia | 0.002367032 | 1 | 0 | GAD |
| Aortic coarctation | 0.002367032 | 1 | 0 | GAD |
| Apnea | 0.002367032 | 1 | 0 | GAD |
| Biliary Tract Neoplasm | 0.002367032 | 1 | 0 | GAD |
| Blood Platelet Disorders | 0.002367032 | 1 | 0 | GAD |
| Bone neoplasms | 0.002367032 | 1 | 0 | GAD |
| Brain Damage, Chronic | 0.002367032 | 1 | 0 | GAD |
| Brain Diseases | 0.002367032 | 1 | 0 | GAD |
| Cerebral Arterial Diseases | 0.002367032 | 1 | 0 | GAD |
| Chorioamnionitis | 0.002367032 | 1 | 0 | GAD |
| Hemophilia B | 0.002367032 | 1 | 0 | GAD |
| Chromosome Deletion | 0.002367032 | 1 | 0 | GAD |
| Connective Tissue Diseases | 0.002367032 | 1 | 0 | GAD |
| Constipation | 0.002367032 | 1 | 0 | GAD |
| Deafness | 0.002367032 | 1 | 0 | GAD |
| Demyelinating Diseases | 0.002367032 | 1 | 0 | GAD |
| Discrete Subaortic Stenosis | 0.002367032 | 1 | 0 | GAD |
| Drug Allergy | 0.002367032 | 1 | 0 | GAD |
| Ehlers-Danlos Syndrome | 0.002367032 | 1 | 0 | GAD |
| Epistaxis | 0.002367032 | 1 | 0 | GAD |
| Escherichia coli Infections | 0.002367032 | 1 | 0 | GAD |
| Esophageal and Gastric Varices | 0.002367032 | 1 | 0 | GAD |
| Femur Head Necrosis | 0.002367032 | 1 | 0 | GAD |
| Fetal Death | 0.002367032 | 1 | 0 | GAD |
| Fibrosis | 0.002367032 | 1 | 0 | GAD |
| Pathological fracture | 0.002367032 | 1 | 0 | GAD |
| Female Genital Diseases | 0.002367032 | 1 | 0 | GAD |
| Hearing Loss, Partial | 0.002367032 | 1 | 0 | GAD |
| Heart Septal Defects | 0.002367032 | 1 | 0 | GAD |
| Hemorrhage | 0.002367032 | 1 | 0 | GAD |
| Hepatitis, Toxic | 0.002367032 | 1 | 0 | GAD |
| HIV Infections | 0.002367032 | 1 | 0 | GAD |
| Neonatal disorder | 0.002367032 | 1 | 0 | GAD |
| Kidney Neoplasm | 0.002367032 | 1 | 0 | GAD |
| Lead Poisoning | 0.002367032 | 1 | 1 | GAD |
| Leukemia, Lymphocytic, Acute, L2 | 0.002367032 | 1 | 0 | GAD |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.002367032 | 1 | 0 | GAD |
| Adult T-Cell Lymphoma/Leukemia | 0.002367032 | 1 | 0 | GAD |
| Alcoholic Liver Diseases | 0.002367032 | 1 | 0 | GAD |
| Lymphatic Metastasis | 0.002367032 | 1 | 0 | GAD |
| Malaria, Falciparum | 0.002367032 | 1 | 0 | GAD |
| Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Marijuana Abuse | 0.002367032 | 1 | 0 | GAD |
| Meningeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Mesenteric Vascular Occlusion | 0.002367032 | 1 | 0 | GAD |
| Mesothelioma | 0.002367032 | 1 | 0 | GAD |
| Mouth Abnormalities | 0.002367032 | 1 | 0 | GAD |
| Muscle hypotonia | 0.002367032 | 1 | 0 | GAD |
| Muscle Spasticity | 0.002367032 | 1 | 0 | GAD |
| Musculoskeletal Diseases | 0.002367032 | 1 | 0 | GAD |
| Myeloproliferative disease | 0.002367032 | 1 | 0 | GAD |
| Nasopharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Nephrosclerosis | 0.002367032 | 1 | 0 | GAD |
| Obesity, Morbid | 0.002367032 | 1 | 0 | GAD |
| Ocular Hypertension | 0.002367032 | 1 | 0 | GAD |
| Pancreatitis | 0.002367032 | 1 | 0 | GAD |
| Panuveitis | 0.002367032 | 1 | 0 | GAD |
| Periodontitis | 0.002367032 | 1 | 0 | GAD |
| Phenylketonurias | 0.002367032 | 1 | 0 | GAD |
| Phlebitis | 0.002367032 | 1 | 0 | GAD |
| Pleural Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Polycythemia | 0.002367032 | 1 | 0 | GAD |
| Protein-Energy Malnutrition | 0.002367032 | 1 | 0 | GAD |
| Proteinuria | 0.002367032 | 1 | 0 | GAD |
| Psychomotor Disorders | 0.002367032 | 1 | 0 | GAD |
| Psychoses, Substance-Induced | 0.002367032 | 1 | 0 | GAD |
| Puerperal Disorders | 0.002367032 | 1 | 0 | GAD |
| Pulmonary Fibrosis | 0.002367032 | 1 | 0 | GAD |
| Pulmonary Valve Stenosis | 0.002367032 | 1 | 0 | GAD |
| Purpura, Thrombotic Thrombocytopenic | 0.002367032 | 1 | 0 | GAD |
| Renal Artery Obstruction | 0.002367032 | 1 | 0 | GAD |
| Respiratory Distress Syndrome, Adult | 0.002367032 | 1 | 0 | GAD |
| Rhinitis, Allergic, Perennial | 0.002367032 | 1 | 0 | GAD |
| Sex Chromosome Aberrations | 0.002367032 | 1 | 0 | GAD |
| Septic Shock | 0.002367032 | 1 | 0 | GAD |
| Splenomegaly | 0.002367032 | 1 | 0 | GAD |
| Subarachnoid Hemorrhage | 0.002367032 | 1 | 0 | GAD |
| Substance Withdrawal Syndrome | 0.002367032 | 1 | 0 | GAD |
| Thrombasthenia | 0.002367032 | 1 | 0 | GAD |
| Urologic Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Venous Insufficiency | 0.002367032 | 1 | 0 | GAD |
| Virilism | 0.002367032 | 1 | 0 | GAD |
| Weight Gain | 0.002367032 | 1 | 0 | GAD |
| Bronchial Hyperreactivity | 0.002367032 | 1 | 0 | GAD |
| Arthritis, Reactive | 0.002367032 | 1 | 0 | GAD |
| Alcoholic Neuropathy | 0.002367032 | 1 | 0 | GAD |
| Hypoplastic Left Heart Syndrome | 0.002367032 | 1 | 0 | GAD |
| Adrenoleukodystrophy | 0.002367032 | 1 | 0 | GAD |
| Iron deficiency anemia | 0.002367032 | 1 | 0 | GAD |
| Right Ventricular Hypertrophy | 0.002367032 | 1 | 0 | GAD |
| Aneurysm, Ruptured | 0.002367032 | 1 | 0 | GAD |
| Neurotoxicity Syndromes | 0.002367032 | 1 | 0 | GAD |
| Acute Lung Injury | 0.002367032 | 1 | 0 | GAD |
| Gonadal Dysgenesis, 45,X | 0.002367032 | 1 | 0 | GAD |
| Oxidative Stress | 0.002367032 | 1 | 0 | GAD |
| Disease Progression | 0.002367032 | 1 | 0 | GAD |
| Multiple Chemical Sensitivity | 0.002367032 | 1 | 0 | GAD |
| Impotence, Vasculogenic | 0.002367032 | 1 | 0 | GAD |
| Sepsis | 0.002367032 | 1 | 0 | GAD |
| Gastroschisis | 0.002367032 | 1 | 0 | GAD |
| Impaired glucose tolerance | 0.002367032 | 1 | 0 | GAD |
| Hemifacial Spasm | 0.002367032 | 1 | 0 | GAD |
| Blind Vision | 0.002367032 | 1 | 0 | GAD |
| body mass | 0.002367032 | 1 | 0 | GAD |
| Retinal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Hepatopulmonary Syndrome | 0.002367032 | 1 | 0 | GAD |
| Epithelial ovarian cancer | 0.002367032 | 1 | 0 | GAD |
| Subarachnoid Hemorrhage, Aneurysmal | 0.002367032 | 1 | 0 | GAD |
| CADASIL Syndrome | 0.002367032 | 1 | 0 | GAD |
| Hypoxia-Ischemia, Brain | 0.002367032 | 1 | 0 | GAD |
| Embryo Loss | 0.002367032 | 1 | 0 | GAD |
| Genomic Instability | 0.002367032 | 1 | 0 | GAD |
| Stenosis | 0.002367032 | 1 | 0 | GAD |
| Gastric Cardia Carcinoma | 0.002367032 | 1 | 0 | GAD |
| Necrotic changes (finding) | 0.002367032 | 1 | 0 | GAD |
| hearing impairment | 0.002367032 | 1 | 0 | GAD |
| ASPIRIN RESISTANCE | 0.002367032 | 1 | 0 | GAD |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.002367032 | 1 | 0 | GAD |
| Proteinuria Adverse Event | 0.002367032 | 1 | 0 | GAD |
| Congenital cardiac malformations | 0.002367032 | 1 | 0 | GAD |
| Weight Gain Adverse Event | 0.002367032 | 1 | 0 | GAD |
| Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | 0.002367032 | 1 | 0 | GAD |
| Recurrent pregnancy loss | 0.002367032 | 1 | 0 | GAD |
| Deficiency of glucose-6-phosphate dehydrogenase | 0.002367032 | 1 | 0 | GAD |
| Granulomatosis with polyangiitis | 0.002367032 | 1 | 0 | GAD |
| Hearing Loss | 0.002367032 | 1 | 0 | GAD |
| Mental disorders | 0.002171535 | 8 | 3 | BeFree |
| Lupus anticoagulant disorder | 0.002171535 | 8 | 1 | BeFree |
| THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | 0.002171535 | 8 | 1 | BeFree |
| Presenile dementia | 0.001900093 | 7 | 0 | BeFree |
| Retinal Diseases | 0.001900093 | 7 | 0 | BeFree |
| Cleft palate with cleft lip | 0.001900093 | 7 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.001900093 | 7 | 1 | BeFree |
| Pancreatic carcinoma | 0.001900093 | 7 | 0 | BeFree |
| Chronic kidney disease stage 5 | 0.001900093 | 7 | 1 | BeFree |
| Malignant neoplasm of mouth | 0.001628651 | 6 | 0 | BeFree |
| Congenital defects | 0.001628651 | 6 | 0 | BeFree |
| Microalbuminuria | 0.001628651 | 6 | 2 | BeFree |
| Arteriopathic disease | 0.001628651 | 6 | 0 | BeFree |
| Macroangiopathy | 0.001628651 | 6 | 0 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.001628651 | 6 | 2 | BeFree |
| Peripheral Arterial Diseases | 0.001628651 | 6 | 0 | BeFree |
| Malignant neoplasm of thyroid | 0.001357209 | 5 | 0 | BeFree |
| Lymphoma, Large-Cell, Follicular | 0.001357209 | 5 | 1 | BeFree |
| Central retinal vein occlusion | 0.001357209 | 5 | 0 | BeFree |
| Portal vein thrombosis | 0.001357209 | 5 | 0 | BeFree |
| Cervical intraepithelial neoplasia grade 2 | 0.001357209 | 5 | 2 | BeFree |
| Non-alcoholic Fatty Liver Disease | 0.001357209 | 5 | 1 | BeFree |
| Thyroid carcinoma | 0.001357209 | 5 | 0 | BeFree |
| vascular disease occlusive | 0.001357209 | 5 | 11 | BeFree |
| Helicobacter pylori infection | 0.001357209 | 5 | 0 | BeFree |
| Acute GVH disease | 0.001357209 | 5 | 0 | BeFree |
| Attention deficit hyperactivity disorder | 0.001357209 | 5 | 4 | BeFree |
| Chronic Kidney Diseases | 0.001357209 | 5 | 1 | BeFree |
| Thrombophilia, hereditary | 0.001357209 | 5 | 0 | BeFree |
| Autoimmune Diseases | 0.001085767 | 4 | 0 | BeFree |
| Deep thrombophlebitis | 0.001085767 | 4 | 0 | BeFree |
| Adenocarcinoma Of Esophagus | 0.001085767 | 4 | 1 | BeFree |
| Colorectal cancer metastatic | 0.001085767 | 4 | 0 | BeFree |
| Childhood Leukemia | 0.001085767 | 4 | 3 | BeFree |
| Autism Spectrum Disorders | 0.001085767 | 4 | 0 | BeFree |
| Anemia, Megaloblastic | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of skin | 0.000814326 | 3 | 0 | BeFree |
| Cervical dysplasia | 0.000814326 | 3 | 0 | BeFree |
| Congenital chromosomal disease | 0.000814326 | 3 | 0 | BeFree |
| Hepatic Vein Thrombosis | 0.000814326 | 3 | 0 | BeFree |
| Microangiopathy, Diabetic | 0.000814326 | 3 | 0 | BeFree |
| Psychotic Disorders | 0.000814326 | 3 | 0 | BeFree |
| Giant Cell Arteritis | 0.000814326 | 3 | 2 | BeFree |
| Hearing Loss, Mixed Conductive-Sensorineural | 0.000814326 | 3 | 0 | BeFree |
| Cholangiocarcinoma | 0.000814326 | 3 | 0 | BeFree |
| Thrombotic stroke | 0.000814326 | 3 | 0 | BeFree |
| Mesenteric Venous Thrombosis | 0.000814326 | 3 | 0 | BeFree |
| Arakawa syndrome 2 | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of colon stage IV | 0.000814326 | 3 | 0 | BeFree |
| Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 3 | BeFree |
| Cerebral venous sinus thrombosis | 0.000814326 | 3 | 0 | BeFree |
| Mood Disorders | 0.000814326 | 3 | 0 | BeFree |
| Maternal hypertension | 0.000814326 | 3 | 0 | BeFree |
| Cystathionine beta-Synthase Deficiency Disease | 0.000814326 | 3 | 0 | BeFree |
| Cerebral Ischemia | 0.000814326 | 3 | 0 | BeFree |
| Gastric Cardia Adenocarcinoma | 0.000814326 | 3 | 1 | BeFree |
| Sporadic Breast Carcinoma | 0.000814326 | 3 | 3 | BeFree |
| CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5 | 0.000814326 | 3 | 1 | BeFree |
| Methylcobalamin Deficiency, CblG Type | 0.000814326 | 3 | 0 | BeFree |
| Experimental Organism Basal Cell Carcinoma | 0.000814326 | 3 | 1 | BeFree |
| Lymphoblastic leukemia in children | 0.000814326 | 3 | 1 | BeFree |
| Anemia, Hemolytic | 0.000542884 | 2 | 1 | BeFree |
| Borderline Personality Disorder | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of endometrium | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of larynx | 0.000542884 | 2 | 0 | BeFree |
| Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Drug habituation | 0.000542884 | 2 | 6 | BeFree |
| Membranous glomerulonephritis | 0.000542884 | 2 | 1 | BeFree |
| Cardiac Arrest | 0.000542884 | 2 | 0 | BeFree |
| Lupus Vulgaris | 0.000542884 | 2 | 0 | BeFree |
| Lupus Erythematosus, Discoid | 0.000542884 | 2 | 0 | BeFree |
| Primary malignant neoplasm of liver | 0.000542884 | 2 | 0 | BeFree |
| Nephrotic Syndrome | 0.000542884 | 2 | 0 | BeFree |
| Ovarian Diseases | 0.000542884 | 2 | 1 | BeFree |
| Adenomatous Polyposis Coli | 0.000542884 | 2 | 0 | BeFree |
| Renal Artery Stenosis | 0.000542884 | 2 | 2 | BeFree |
| Spina Bifida Cystica | 0.000542884 | 2 | 0 | BeFree |
| Ankylosing spondylitis | 0.000542884 | 2 | 0 | BeFree |
| Vitiligo | 0.000542884 | 2 | 0 | BeFree |
| Precursor cell lymphoblastic lymphoma | 0.000542884 | 2 | 3 | BeFree |
| Depressive Symptoms | 0.000542884 | 2 | 0 | BeFree |
| Sicca Syndrome | 0.000542884 | 2 | 0 | BeFree |
| Small cell carcinoma of lung | 0.000542884 | 2 | 0 | BeFree |
| Oral Cavity Carcinoma | 0.000542884 | 2 | 1 | BeFree |
| Disease of capillaries | 0.000542884 | 2 | 0 | BeFree |
| Fibrosis, Liver | 0.000542884 | 2 | 0 | BeFree |
| Dyslipidemias | 0.000542884 | 2 | 0 | BeFree |
| Renal sclerosis with hypertension | 0.000542884 | 2 | 1 | BeFree |
| Severe hereditary factor VIII deficiency disease | 0.000542884 | 2 | 0 | BeFree |
| Stage III Colon Cancer | 0.000542884 | 2 | 0 | BeFree |
| Venous retinal branch occlusion | 0.000542884 | 2 | 0 | BeFree |
| Nonorganic psychosis | 0.000542884 | 2 | 0 | BeFree |
| Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
| Chronic Kidney Insufficiency | 0.000542884 | 2 | 1 | BeFree |
| Chronic rejection of renal transplant | 0.000542884 | 2 | 0 | BeFree |
| Lupus Erythematosus | 0.000542884 | 2 | 0 | BeFree |
| Primary antiphospholipid syndrome | 0.000542884 | 2 | 0 | BeFree |
| Endometrial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Secondary malignant neoplasm of liver | 0.000542884 | 2 | 0 | BeFree |
| Neurodegenerative Disorders | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of skin | 0.000542884 | 2 | 0 | BeFree |
| Hemophilia, NOS | 0.000542884 | 2 | 1 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.000542884 | 2 | 0 | BeFree |
| cardiac event | 0.000542884 | 2 | 0 | BeFree |
| Brain Tumor, Primary | 0.000542884 | 2 | 0 | BeFree |
| Transient Cerebral Ischemia | 0.000542884 | 2 | 0 | BeFree |
| Mild cognitive disorder | 0.000542884 | 2 | 2 | BeFree |
| Differentiated Thyroid Gland Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| alpha^+^ Thalassemia | 0.000542884 | 2 | 0 | BeFree |
| Vitamin Deficiency | 0.000542884 | 2 | 0 | BeFree |
| Rectal Tumors | 0.000542884 | 2 | 0 | BeFree |
| Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.000542884 | 2 | 0 | BeFree |
| Oral Mucositis | 0.000542884 | 2 | 0 | BeFree |
| Glioblastoma Multiforme | 0.000542884 | 2 | 2 | BeFree |
| Non-Neoplastic Disorder | 0.000542884 | 2 | 0 | BeFree |
| Meningioma, benign, no ICD-O subtype | 0.000542884 | 2 | 0 | BeFree |
| Azoospermia, Nonobstructive | 0.000542884 | 2 | 1 | BeFree |
| VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.000542884 | 2 | 0 | BeFree |
| Nonarteritic anterior ischemic optic neuropathy (NAION) | 0.000542884 | 2 | 0 | BeFree |
| Uterine Corpus Cancer | 0.000542884 | 2 | 0 | BeFree |
| Acquired thrombophilia | 0.000542884 | 2 | 0 | BeFree |
| Stage III Colon Cancer AJCC v7 | 0.000542884 | 2 | 0 | BeFree |
| Nonalcoholic Steatohepatitis | 0.000542884 | 2 | 0 | BeFree |
| Juvenile rheumatoid arthritis | 0.000542884 | 2 | 0 | BeFree |
| Acute pancreatitis | 0.000271442 | 1 | 0 | BeFree |
| Affective Disorders, Psychotic | 0.000271442 | 1 | 0 | BeFree |
| Osteoporosis, Age-Related | 0.000271442 | 1 | 0 | BeFree |
| alcohol use disorder | 0.000271442 | 1 | 1 | BeFree |
| Anxiety Disorders | 0.000271442 | 1 | 0 | BeFree |
| Arteriovenous fistula | 0.000271442 | 1 | 0 | BeFree |
| Female Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cerebral Atherosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Cervix Diseases | 0.000271442 | 1 | 0 | BeFree |
| Developmental Disabilities | 0.000271442 | 1 | 0 | BeFree |
| Cluster Headache | 0.000271442 | 1 | 1 | BeFree |
| Cytomegalovirus Infections | 0.000271442 | 1 | 0 | BeFree |
| Senile dementia | 0.000271442 | 1 | 0 | BeFree |
| Dry Eye Syndromes | 0.000271442 | 1 | 0 | BeFree |
| Dyspnea | 0.000271442 | 1 | 0 | BeFree |
| Eczema | 0.000271442 | 1 | 0 | BeFree |
| Breast Fibrocystic Disease | 0.000271442 | 1 | 0 | BeFree |
| Fibromyalgia | 0.000271442 | 1 | 0 | BeFree |
| Primary angle-closure glaucoma | 0.000271442 | 1 | 0 | BeFree |
| Headache | 0.000271442 | 1 | 0 | BeFree |
| Hemochromatosis | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis | 0.000271442 | 1 | 1 | BeFree |
| Hepatitis A | 0.000271442 | 1 | 1 | BeFree |
| Malaria | 0.000271442 | 1 | 0 | BeFree |
| melanoma | 0.000271442 | 1 | 1 | BeFree |
| Premature Menopause | 0.000271442 | 1 | 0 | BeFree |
| Moyamoya Disease | 0.000271442 | 1 | 0 | BeFree |
| Neuroblastoma | 0.000271442 | 1 | 4 | BeFree |
| Pain | 0.000271442 | 1 | 0 | BeFree |
| Papilloma | 0.000271442 | 1 | 0 | BeFree |
| Pneumonia | 0.000271442 | 1 | 0 | BeFree |
| Quadriplegia | 0.000271442 | 1 | 0 | BeFree |
| Sickle Cell Trait | 0.000271442 | 1 | 0 | BeFree |
| Smallpox | 0.000271442 | 1 | 0 | BeFree |
| Temporomandibular Joint Disorders | 0.000271442 | 1 | 0 | BeFree |
| Temporomandibular Joint Dysfunction Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Tonsillitis | 0.000271442 | 1 | 0 | BeFree |
| Uremia | 0.000271442 | 1 | 0 | BeFree |
| Varicocele | 0.000271442 | 1 | 1 | BeFree |
| Wheezing | 0.000271442 | 1 | 0 | BeFree |
| Ovarian Hyperstimulation Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Ovarian Failure, Premature | 0.000271442 | 1 | 0 | BeFree |
| Pyoderma Gangrenosum | 0.000271442 | 1 | 0 | BeFree |
| Idiopathic Membranous Glomerulonephritis | 0.000271442 | 1 | 0 | BeFree |
| Complete trisomy 18 syndrome | 0.000271442 | 1 | 0 | BeFree |
| Recurrent major depressive episodes | 0.000271442 | 1 | 0 | BeFree |
| Old myocardial infarction | 0.000271442 | 1 | 0 | BeFree |
| Congenital anomaly of aortic arch | 0.000271442 | 1 | 0 | BeFree |
| Angelman Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Diplegia | 0.000271442 | 1 | 1 | BeFree |
| Lesion of brain | 0.000271442 | 1 | 1 | BeFree |
| Disorder of vein | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of female breast | 0.000271442 | 1 | 0 | BeFree |
| Bipolar II disorder | 0.000271442 | 1 | 0 | BeFree |
| Neoplasm, Residual | 0.000271442 | 1 | 1 | BeFree |
| Carcinoma, Small Cell | 0.000271442 | 1 | 0 | BeFree |
| Childhood asthma | 0.000271442 | 1 | 0 | BeFree |
| Xeroderma Pigmentosum, Complementation Group D | 0.000271442 | 1 | 0 | BeFree |
| Gastric Adenocarcinoma | 0.000271442 | 1 | 1 | BeFree |
| Non-small cell lung cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
| Solid tumour | 0.000271442 | 1 | 0 | BeFree |
| Primary central nervous system lymphoma | 0.000271442 | 1 | 1 | BeFree |
| Dryness of eye | 0.000271442 | 1 | 0 | BeFree |
| Anastomosis | 0.000271442 | 1 | 0 | BeFree |
| Squamous intraepithelial lesion | 0.000271442 | 1 | 0 | BeFree |
| Non-arteritic ischemic optic neuropathy | 0.000271442 | 1 | 0 | BeFree |
| Proliferative retinopathy | 0.000271442 | 1 | 0 | BeFree |
| Lemierre Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Double inlet left ventricle | 0.000271442 | 1 | 0 | BeFree |
| Cervical intraepithelial neoplasia grade 1 | 0.000271442 | 1 | 0 | BeFree |
| Diagnosis, Psychiatric | 0.000271442 | 1 | 0 | BeFree |
| Neuropathy | 0.000271442 | 1 | 0 | BeFree |
| Pervasive Development Disorder | 0.000271442 | 1 | 0 | BeFree |
| Palmar-plantar erythrodysesthesia syndrome | 0.000271442 | 1 | 0 | BeFree |
| Severe depression | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of larynx | 0.000271442 | 1 | 0 | BeFree |
| Leukemogenesis | 0.000271442 | 1 | 0 | BeFree |
| Emotional problems | 0.000271442 | 1 | 0 | BeFree |
| Central neuroblastoma | 0.000271442 | 1 | 4 | BeFree |
| Dissecting aneurysm of the thoracic aorta | 0.000271442 | 1 | 0 | BeFree |
| Subfertility | 0.000271442 | 1 | 0 | BeFree |
| End Stage Liver Disease | 0.000271442 | 1 | 0 | BeFree |
| Anterior Ischemic Optic Neuropathy | 0.000271442 | 1 | 0 | BeFree |
| Sickle Cell Dactylitis | 0.000271442 | 1 | 0 | BeFree |
| Myelosuppression | 0.000271442 | 1 | 0 | BeFree |
| Psychotic symptom | 0.000271442 | 1 | 0 | BeFree |
| Skin toxicity | 0.000271442 | 1 | 1 | BeFree |
| Hereditary Nonpolyposis Colorectal Cancer | 0.000271442 | 1 | 1 | BeFree |
| Avascular necrosis of the capital femoral epiphysis | 0.000271442 | 1 | 0 | BeFree |
| Severe diarrhea | 0.000271442 | 1 | 0 | BeFree |
| Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
| Nephrotic Syndrome, Minimal Change | 0.000271442 | 1 | 0 | BeFree |
| Dysmorphism | 0.000271442 | 1 | 0 | BeFree |
| Fast acetylator due to N-acetyltransferase enzyme variant | 0.000271442 | 1 | 0 | BeFree |
| TIBIAL MUSCULAR DYSTROPHY, TARDIVE | 0.000271442 | 1 | 0 | BeFree |
| malignant neoplasm of large intestine stage IV | 0.000271442 | 1 | 0 | BeFree |
| Infarction of spinal cord | 0.000271442 | 1 | 0 | BeFree |
| Steatohepatitis | 0.000271442 | 1 | 1 | BeFree |
| Moyamoya disease 1 | 0.000271442 | 1 | 0 | BeFree |
| Nasopharyngeal carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Severe dementia | 0.000271442 | 1 | 0 | BeFree |
| Hypertensive end stage renal disease | 0.000271442 | 1 | 0 | BeFree |
| Allergic disposition | 0.000271442 | 1 | 0 | BeFree |
| Allergic sensitization | 0.000271442 | 1 | 0 | BeFree |
| Pneumonitis | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。